Personalized approaches to sepsis management
16 Jan 2025
Find out how the management of sepsis can be personalized for patients in this presentation from the 2024 World Sepsis Congress Spotlight: Unmet Need in Sepsis Diagnosis and Therapy. Topics discussed in this video include how ARDS (Acute respiratory distress syndrome) treatment can be personalized, the use of macrolides in CAP (Community-acquired pneumonia), the TREM-1 pathway, and how immunoparalysis in response to sepsis can be reversed.
00:00:00 Introduction
00:00:44 Bruno Francois, Dupuytren University Hospital, France – TREM-1 Pathway
00:11:41 Carolyn Calfee, University of California, San Francisco Medical Center, USA – ARDS: Room for Precision Treatment?
00:25:48 Sara Cajander, Amsterdam UMC, The Netherlands – Reversal of Immunoparalysis
00:35:29 Michael Niederman, Weill Cornell Medicine, USA – Macrolides for Community-Acquired Pneumonia
00:46:26 Alexander Vlaar, Örebro University Hospital, Sweden – Modulation of Complement
01:00:41 Q&A
About the company
Global Sepsis Alliance
The Global Sepsis Alliance (GSA) is a non-profit charity organization with the mission to provide global leadership to reduce the worldwide burden of sepsis. The GSA is the initiator of World Sepsis Day on September 13 and World Sepsis Congress, a series of free online congresses bringing knowledge about sepsis to all parts of the world, among other initiatives.
The GSA works closely with its over 120 member organizations from all over the world – patient advocacy groups, professional societies, healthcare authorities, and governments – to implement changes on how sepsis is prioritized, diagnosed, and treated all around the world, as laid out in the WHO Resolution on Sepsis.
